Kleangas Energy Technologies IncOTC: KGET

CaliPharms CEO to Attend The Business of Bud: 2017 Cannabis Industry Update at Golden Gate University in San Francisco

· Issued by Kleangas Energy Technologies Inc

CaliPharms, Inc. (OTCPink:KGET), a Company operating in the California Medicinal Cannabis industry, which trades under its former name “Kleangas Energy Technologies, Inc.” is pleased to announce the company CEO, Bo Linton, is on the registered guest list to attend the Sold Out event, “The Business of Bud: 2017 Cannabis Industry Update,“ at Golden Gate University in San Francisco, CA.

https://cfa-sf.site-ym.com/events/EventDetails.aspx?id=911178

Pro Cannabis votes across the country enacted "legal" access for over 50% of US adults.  What spurred this change?  Is it just about getting high or is there something bigger?  Will it spawn the next Budweiser, Jack Daniels or Genentech?  Sifting through the American Medical Journal or High Times, it could be all of the above. Major banks and investment companies are quietly (and sometimes not so quietly) researching the gold rush for MJ aka the Green Rush.  There could be great opportunities and most certainly great pitfalls. 

Join CFA Society San Francisco on February 23rd for an educational event to discuss the topic with recognized leaders on cannabis market research, investment, and regulation. 


Event Chairperson: Lynne Gravelle Mosier, CFA
  

Panelists:

Tim Morland, Director of Legislative and Regulatory Affairs, State Board of Equalization, State of California. 

Tim has extensive knowledge of the California legislative process. Tim was hired by the State Board of Equalization Member Fiona Ma in January of 2015 as the Assistant Legislative and Regulatory Affairs Director. In November of 2015, he was promoted to Director of Legislative and Regulatory Affairs. He currently serves on the Cannabis Compliance project within the State Board of Equalization. Prior to joining Board Member Fiona Ma's team, Tim served in the Assembly Chief Clerk's Office, the Assembly Daily File Clerk and the Reading Clerk for the California State Assembly. He graduated from California State University Sacramento with high honors in 2008 (Phi Kappa Phi)with a degree in Government

Troy Dayton, Arcview investment

Arcview is a leading source of investment deal flow in the cannabis industry and active in market research and analysis.Troy is frequently quoted in the NYTimes, Washington Post, Fortune, CNN, NPR, Fox, Bloomberg and CNBC.  Arcview's group of 600+ high net worth investors have allocated  more than $91 million into 135 cannabis related companies. Troy cofounded cannabis business accelerator Canopy and cannabis insurance company Cannasure. Troy is a board member for the Marijuana Policy Project and was formerly their top fundraiser and lead liaison to the legal cannabis industry. He is a founding board member of the National Cannabis Industry Association and co-founder of Students for Sensible Drug Policy, which is now on over 300 campuses. He was recently named by Fortune Magazine as one of the top 7 most powerful people in the cannabis industry.

Morgan Paxhia, Co-Founder, Poseidon Asset Management

Poseidon Asset Management is a hedge fund focused on the cannabis industry. Since 2013 Poseidon has invested in 30+ cannabis related companies across technology, data analytics, agtech, real estate, media, biotech, cultivation and industrial hemp processing. Morgan has developed investment methodology in a highly inefficient emerging industry and created frameworks for analysis based on sub-sector, company stage, capital participation and other metrics to diversify risk for investors.  Morgan has been quoted in the WSJ, Barrons, Fortune, CNBC and many other publications.  Earlier in his career he was in asset management with UBS. Morgan earned his Bachelor of Science in Applied Mathematics from the University of Rhode Island.

President and CEO Bo Linton stated, “ This is a great opportunity for CaliPharms to become educated on the latest California Cannabis trends and regulations. It is my job to navigate CaliPharms through this highly regulated industry, and being educated and well informed is the best way for our company to compete on the highest levels in the inductry.”

For up to date information on the company please follow us @

facebook.com/CaliPharms

twitter.com/CaliPharms

About CaliPharms, Inc. 

CaliPharms Inc., trading under the symbol (KGET) which trades under its former name “Kleangas Energy Technologies, Inc.” is a medical marijuana-cannabis business. The Company operates through its 51% owned subsidiary County Junction Farms, Inc. within the State of California. The Company currently is focused within the medical marijuana-cannabis industry. The second tier of development for the company will be to expand into other sectors that support the legalized cannabis industry. The company intends to expand its operations as the laws for each individual State change and allow.

About Country Junction Farms, Inc.

Founded in 2010, Country Junction Farms is a fully permitted cultivator of medical cannabis within the State of California.

Safe Harbor Statement: 

Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as CaliPharms or KGET or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Investment into a microcap company is a high risk investment and it should only be considered if you are able to afford a total loss of the investment. Laws and Regulations of Marijuana are currently in direct contradiction between California and Federal Law and these factors should be a part of your consideration when making an investment into KGET.

Company Contact: 

CaliPharms, Inc. (KGET)

www.CaliPharmsInc.com

facebook.com/CaliPharms

twitter.com/CaliPharms

Telephone 1-949-800-6645

Email: info@CaliPharmsInc.com

Company analysis